We report the GALLEX solar neutrino results for the measuring period GALLEX IV, from 14
February 1996 until 23 January 1997. Counting for the GALLEX IV runs was completed on 19 …

Immune checkpoint inhibitor (ICI) treatments benefit some patients with metastatic cancers,
but predictive biomarkers are needed. Findings in selected cancer types suggest that tumor …

Background Nivolumab, a fully human IgG4 PD-1 immune checkpoint inhibitor antibody,
can result in durable responses in patients with melanoma who have progressed after …

Objectives Odors are powerful emotional stimuli influencing mood, attention and behavior.
Here we examined if odors change the perception of pleasant touch. In line with the warning …

Background Patients with advanced sarcomas have a poor prognosis and few treatment
options that improve overall survival. Chemotherapy and targeted therapies offer short-lived …

The Brazilian Amazon contains about 40% of the world's remaining tropical rainforest and
plays vital roles in maintaining biodiversity, regional hydrology and climate, and terrestrial …

We have measured the rate of production of 71 Ge from 71 Ga by solar neutrinos. The target
consists of 30.3 t of gallium in the form of 8.13 M aqueous gallium chloride solution (101 t), …

Background Merkel cell carcinoma is a rare, aggressive skin cancer with poor prognosis in
patients with advanced disease. Current standard care uses various cytotoxic chemotherapy …

We report the first GNO solar neutrino results for the measuring period GNO I, solar exposure
time May 20, 1998 till January 12, 2000. In the present analysis, counting results for solar …

We report the complete GNO solar neutrino results for the measuring periods GNO III, GNO II,
and GNO I. The result for GNO III (last 15 solar runs) is [54.3 −9.3 +9.9 (stat)±2.3(syst)]SNU(…